News Focus
News Focus
Followers 4
Posts 319
Boards Moderated 0
Alias Born 04/04/2024

Re: Hoskuld post# 503920

Wednesday, 10/22/2025 9:17:43 AM

Wednesday, October 22, 2025 9:17:43 AM

Post# of 519103
His ALZ figures at 40% I think are high. Also possible competition has been fully ignored. But....we very well may have an approved Schizo drug and that is not accounted for. All up in the air. No offense, but that shows a lack of experience. Jesse has ten years of investing experience. Per his bio. The fact is No One Knows the real level of Blarcamesine acceptance but given it will be the FIRST ALZ med with some hard data, oral rather than a drip and MRI, etc. I think a reasonable level of scrips will be written. 40 to 70%, no. $100B market cap, very doubtful. I think the company will be acquired by BP after an EMA & FDA approval personally for the $10-20 billion range as reasonable for all parties.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News